Lamotrigine in the treatment of SUNCT syndrome
- 13 November 2001
- journal article
- case report
- Published by Wolters Kluwer Health in Neurology
- Vol. 57 (9) , 1723-1725
- https://doi.org/10.1212/wnl.57.9.1723
Abstract
Short-lasting, unilateral, neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) is considered an intractable condition. The authors treated five patients with lamotrigine (125 to 200 mg daily), obtaining a complete remission in three patients and a substantial reduction (about 80%) of attack frequency in the other two. No adverse effects were noted.Keywords
This publication has 10 references indexed in Scilit:
- Two New SUNCT Cases Responsive to LamotrigineCephalalgia, 2000
- Anticonvulsants for Neuropathic Pain SyndromesDrugs, 2000
- Possible usefulness of lamotrigine in the treatment of SUNCT syndromeNeurology, 1999
- A review of paroxysmal hemicranias, SUNCT syndrome and other short- lasting headaches with autonomic feature, including new casesBrain, 1997
- Effect of lamotrigine in the acute and chronic hyperalgesia induced by PGE2 and in the chronic hyperalgesia in rats with streptozotocin-induced diabetesPain, 1995
- Interaction of the antiepileptic drug lamotrigine with recombinant rat brain type IIA Na+ channels and with native Na+ channels in rat hippocampal neuronesPflügers Archiv - European Journal of Physiology, 1995
- SUNCT Syndrome: Trials of Drugs and Anesthetic BlockadesHeadache: The Journal of Head and Face Pain, 1995
- “SUNCT” Syndrome. A Case of Transformation from Trigeminal Neuralgia?Cephalalgia, 1994
- Short-Lasting Unilateral Neuralgiform Headache Attacks with Tearing and Conjunctival Injection: The First “Symptomatic” Case?Cephalalgia, 1991
- Shortlasting, Unilateral Neuralgiform Headache Attacks with Conjunctival Injection, Tearing, Sweating, and RhinorrheaCephalalgia, 1989